Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | APP | P05067 | 3/20 | 0.48 |
| ▸ | KIF11 | P52732 | 1/20 | 0.47 |
| ▸ | ALDH5A1 | P51649 | 3/20 | 0.47 |
| ▸ | ABAT | P80404 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.47 |
| ▸ | P4HB | P07237 | 2/20 | 0.44 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.43 |
| ▸ | NQO2 | P16083 | 1/20 | 0.42 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL856316 | 1.00 | KDM4E (0.57) | KDM4EPTGS2RAB9AAPPKIF11 | |
| SCHEMBL24445838 | 0.84 | KDM4E (0.57) | KDM4EPTGS2RAB9AAPPKIF11 | |
| SCHEMBL13257342 | 0.83 | KDM4E (0.61) | KDM4EPTGS2RAB9AALDH5A1ABAT | |
| SCHEMBL16552545 | 0.81 | HSD17B1 (0.54) | KDM4EPTGS2RAB9AAPPKIF11 | |
| SCHEMBL472408 | 0.81 | KIF11 (0.56) | KDM4EPTGS2RAB9AAPPKIF11 | |
| SCHEMBL2632511 | 0.80 | PTGS2 (0.57) | KDM4EPTGS2RAB9AALDH5A1ABAT | |
| SCHEMBL30500661 | 0.80 | PTGS2 (0.57) | KDM4EPTGS2RAB9AALDH5A1ABAT | |
| SCHEMBL7879191 | 0.80 | TRPA1 (0.47) | PTGS2APPALDH1A1P4HBNQO2 | |
| SCHEMBL6855509 | 0.79 | KIF11 (0.50) | KDM4EPTGS2RAB9AAPPKIF11 | |
| SCHEMBL11971417 | 0.78 | APP (0.60) | KDM4EAPPALDH1A1HPGDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118546363-A | Polyimide film and production process thereof | 江苏韵升绝缘科技有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-121209001-B | High-fiber-density windable optical fiber ribbon and preparation method thereof | 江苏亨通光电股份有限公司 | 2026-03-17 | — | — | CN | disclosed |
| CN-121209001-A | High-fiber-density windable optical fiber ribbon and preparation method thereof | 江苏亨通光电股份有限公司 | 2025-12-26 | — | — | CN | disclosed |
| CN-119752318-A | Photosensitive polyimide coating adhesive and preparation method and application thereof | 波米科技有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-114341135-B | Estrogen-related receptor alpha (erra) modulators | 领先制药控股公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-113365995-B | Immunomodulators, compositions and methods thereof | 贝达药业股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-118878461-A | PD-1/PD-L1 inhibitors | 吉利德科学公司 | 2024-11-01 | — | — | CN | disclosed |
| WO-2024183756-A1 | BENZENE RING-CONTAINING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海再极医药科技有限公司 | 2024-09-12 | — | — | WO | disclosed |
| CN-118619942-A | Benzene ring-containing compound and preparation method and application thereof | 上海再极医药科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-118546363-A | Polyimide film and production process thereof | 江苏韵升绝缘科技有限公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-117858865-A | CBL-B modulators and uses thereof | 林伯士克莱奥公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117586272-A | Heterocyclic compound, preparation method and application thereof in medicine | 苏州信诺维医药科技股份有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-111954525-B | Prodrugs of fused bicyclic C5aR antagonists | 凯莫森特里克斯股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-111615515-B | Heterocyclic compound, preparation method and application thereof in medicine | 苏州信诺维医药科技股份有限公司 | 2023-11-24 | — | — | CN | disclosed |
| EP-3741759-B1 | IMIDAZO[1,2-A]PYRIMIDINE AND IMIDAZO[1,2-C]PYRIMIDINE COMPOUNDS AND USE THEREOF IN THE TREATMENT OF HYPERURICEMIA AND GOUT | EVOPOINT BIOSCIENCES CO LTD (CN) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023024425-A1 | TRIAZOLONE COMPOUND AND MEDICINAL USE THEREOF | 中国药科大学 | 2023-03-02 | — | — | WO | disclosed |
| US-11453674-B2 | Heterocyclic compound, preparation method and use thereof in medicine | Evopoint Biosciences Co., Ltd. (CN) | 2022-09-27 | — | — | US | disclosed |
| CN-112979661-B | Heterocyclic compound, preparation method and application thereof in medicine | 苏州信诺维医药科技股份有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-114341135-A | Estrogen-related receptor alpha (ERR alpha) modulators | 领先制药控股公司 | 2022-04-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11453674-B2 | Heterocyclic compound, preparation method and use thereof in medicine | PAH, NLRP3, CYP11B2 | KDM4E 2925/4885PTGS2 1538/4885RAB9A 3500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.